AirXpanders Inc., is a tissue-expansion company focused on the area of breast cancer reconstruction. By employing a revolutionary patient-controlled expander, activated by a wireless remote control, the often painful process of recovering one's feminine shape after cancer can potentially be eased with this needle-free technology that is easy to use and may enable the patient to proceed to a permanent implant much faster than the current standard-of-care. At this time, AirXpanders' products are not cleared or approved for sale.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/24/12 | $10,000,000 | Series D |
GBS Venture Partners Heron Capital Prolog Ventures Vivo Ventures WTI | undisclosed |
